Anatomic pathology instruments and reagents

Elecsys® Toxo IgG

Immunoassay for the quantitative determination of IgG-antibodies against Toxoplasma gondii

Elecsys® Toxo IgM

Immunoassay for the qualitative determination of IgM-antibodies against Toxoplasma gondii

Elecsys® Toxo IgG Avidity

Immunoassay for the qualitative determination of T. gondii IgG avidity

Breast cancer IHC/ISH portfolio

Breast cancer diagnostic tools with clinical and analytical superiority.

Elecsys® Vitamin D total II

Vitamin D total II – Allowing better patient care with results you can trust

DISCOVERY XT IHC/ISH Research Platform

DISCOVERY XT IHC/ISH Research Platform

Colorectal IHC portfolio

The Roche colorectal assay portfolio, including IHC diagnostic assays, deliver the high sensitivity and specificity pathology professionals need.

BenchMark GX IHC ISH System

BenchMark GX is designed for laboratories manually performing immunohistochemistry and/or in situ hybridization, and where consistency, efficiency and quality are of utmost importance.

Dermatopathology IHC portfolio

Powerful tools that help pathologists with dermatopathology diagnostics from Roche.

Lung cancer IHC portfolio

Helping pathologists perform lung cancer diagnoses, IHC diagnostic assays that deliver high sensitivity and specificity.

VENTANA Companion Algorithm image analysis software

Image analysis algorithms empowering precision diagnosis.

Prostate cancer IHC portfolio

Prostate cancer diagnostic assays that help pathologists make more accurate and detailed diagnoses.

VENTANA DP 200

Robust high-speed scanning empowers precision diagnosis.

Hematopathology cancer IHC portfolio

Powerful tools that help pathologists with hematopathology diagnostics.

VENTANA PD-L1 (SP142) Assay (CE IVD)

VENTANA PD-L1 (SP142) Assay is intended for the immunohistochemical assessment of the programmed death-ligand 1 (PD-L1) protein in tumour cells and tumour infiltrating immune cells in formalin-fixed, paraffin-embedded (FFPE) tumour tissue stained with OptiView DAB IHC Detection Kit and OptiView Amplification Kit on a VENTANA BenchMark IHC/ISH instrument.

VENTANA PD-L1 (SP263) Assay (CE IVD)

VENTANA PD-L1 (SP263) Assay is intended for the qualitative detection of the programmed death ligand 1 (PD-L1) protein in formalin-fixed, paraffin-embedded (FFPE) non-small cell lung cancer (NSCLC), urothelial carcinoma (UC) and other tumour tissues stained with OptiView DAB IHC Detection Kit on a BenchMark IHC/ISH instrument.